The physicians of Illinois CancerCare, P.C. have a wide range of research interests that deal with cancer treatment, cancer prevention, and symptom management. Through the Heartland Cancer Research National Cancer Institute Community Oncology Research Program (Heartland Cancer Research NCORP), the physicians are able to bring state-of-the-art cancer research to the residents of central and western Illinois. The physicians of Illinois CancerCare participate in research with many large national cancer research bases, including the Alliance for Clinical Trials in Oncology (Alliance), ECOG-ACRIN Cancer Research Group, NRG Oncology, Southwest Oncology Group, the University of Rochester Cancer Consortium (URCC) as well as other top medical research facilities, such as Mayo Clinic.
The physicians also have a strong interest in promising new agents that can be used alone or in combination with standard accepted therapies. The physicians maintain a membership in the University of Chicago’s Personalized Cancer Care Consortium (PCCC) and continue to participate directly with numerous pharmaceutical companies, opening doors to the promising new agents that could become the standard therapy of tomorrow. Illinois CancerCare has a history of bringing quality, groundbreaking research opportunities to the people of central and western Illinois both in the treatment and in the prevention of cancer. Illinois CancerCare played a part in early research of drugs like Oxaliplatin, CPT-11, and Procrit, which have become very important parts of the arsenal of chemotherapy and supportive drugs.
Currently, Illinois CancerCare has clinical trials for many types of cancers. Therapies include many new biological agents and targeting compounds. For a listing of current trials, please visit the clinical trials section of the website. For more information about a specific clinical trial, please contact Illinois CancerCare at 1-800-793-2262.